RT Book, Section
A1 Long, Jill
A1 Shvartsman, Katerina
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1184751602
T1 Contraception & Family Planning
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1184751602
RD 2024/04/19
AB KEY  CLINICAL  UPDATES  IN  CONTRACEPTION  &  FAMILY  PLANNINGA  different  on-demand  vaginal  contraceptive,  a  vaginal  pH  regulator  gel  containing  lactic  acid-citric  acid-potassium  bitartrate  (Phexxi),  was  FDA  approved  for  use  in  the  United  States  in  2020.In  a  clinical  study  of  the  efficacy  of  Phexxi,  the  7-cycle  cumulative  pregnancy  risk  was  7%  when  used  as  directed  and  14%  with  typical  use.